# Multicenter Trial of Antithrombotic Strategies in Acute Coronary Syndrome With Coronary Artery Ectasia

> **NCT07511257** · PHASE4 · RECRUITING · sponsor: **Instituto Nacional de Cardiologia Ignacio Chavez** · enrollment: 326 (estimated)

## Conditions studied

- Coronary Artery Ectasia
- Acute Coronary Syndromes (ACS)
- STEMI - ST Elevation Myocardial Infarction
- NSTEMI - Non-ST Segment Elevation Myocardial Infarction (MI)

## Interventions

- **DRUG:** Aspirin 100 mg
- **DRUG:** Clopidogrel 75 mg
- **DRUG:** Rivaroxaban 15 mg

## Key facts

- **NCT ID:** NCT07511257
- **Lead sponsor:** Instituto Nacional de Cardiologia Ignacio Chavez
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-02-11
- **Primary completion:** 2029-06
- **Final completion:** 2029-06
- **Target enrollment:** 326 (ESTIMATED)
- **Last updated:** 2026-04-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07511257

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07511257, "Multicenter Trial of Antithrombotic Strategies in Acute Coronary Syndrome With Coronary Artery Ectasia". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT07511257. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*